161 Results

People

  1. Aghajanian
    Aghajanian
  2. Sabbatini
    Sabbatini
  3. Hensley
    Hensley
  4. Spriggs
    Spriggs
  5. Barakat
    Barakat
  6. Abu-Rustum
    Abu-Rustum
  7. Lichtman
    Lichtman
  8. Chi
    Chi
  9. Makker
    Makker
  10. Tew
    Tew

Groups

  1. Department of Medicine (161)
  2. Gynecologic Medicine Service (161)
  3. Solid Tumor Oncology Division (161)
  4. Gynecology Disease Management Team (139)
  5. GDMT, Medicine (138)
  6. Surgery (52)
  7. GDMT, Surgery (46)
  8. Epidemiology and Biostatistics (39)
  9. Biostatistics Service (37)
  10. Survivorship Research (22)
  1. "paclitaxel"
  2. "Gynecologic Medicine Service"
Formats
  1. Journal Article (158)
  2. Editorial (1)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Department of Medicine (161)
  2. Gynecologic Medicine Service (161)
  3. Solid Tumor Oncology Division (161)
  4. Gynecology Disease Management Team (139)
  5. GDMT, Medicine (138)
  6. Surgery (52)

More Groups

People
  1. Carol Aghajanian (64)
  2. Paul Sabbatini (48)
  3. David Spriggs (33)
  4. Martee Hensley (33)
  5. Richard Barakat (26)
  6. Nadeem Abu-Rustum (25)

More People

Years
  1. 2024 (3)
  2. 2023 (8)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Gynecologic Oncology (63)
  2. Journal of Clinical Oncology (14)
  3. International Journal of Gynecological Cancer (8)
  4. Journal of the National Comprehensive Cancer Network (7)
  5. The Oncologist (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (78)
  2. American Society of Clinical Oncology (14)
  3. Lippincott Williams & Wilkins (11)
  4. Springer (10)
  5. Harborside Press (7)
  6. Oxford University Press (7)

More Publishers

Results (161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of East Asia subgroup in Study 309/KEYNOTE-775: Lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
    Journal Article

    Yonemori, K.; Fujiwara, K.; Hasegawa, K.; Yunokawa, M.; Ushijima, K.; Suzuki, S.; Shikama, A.; Minobe, S.; Usami, T.; Kim, J. W.; more...
    Journal of Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Decreased HER2 expression in endometrial cancer following anti-HER2 therapy
    Journal Article

    Chui, M. H.; Brown, D. N.; Da Cruz Paula, A.; da Silva, E. M.; Momeni-Boroujeni, A.; Reis-Filho, J. S.; Zhang, Y.; Makker, V.; Ellenson, L. H.; Weigelt, B.
    Journal of Pathology (2024)

    Fulltext@MSK | Save
  • Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer
    Journal Article

    Boerner, T.; Lam, C.; Basaran, D.; Liu, Y. L.; Grisham, R. N.; Tew, W. P.; Long Roche, K.; Zivanovic, O.; Abu-Rustum, N. R.; Gardner, G. J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Molecular results and potential biomarkers identified from the phase 3 MILO/ENGOT-ov11 study of binimetinib versus physician choice of chemotherapy in recurrent low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Vergote, I.; Banerjee, S.; Drill, E.; Kalbacher, E.; Mirza, M. R.; Romero, I.; Vuylsteke, P.; Coleman, R. L.; Hilpert, F.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • A randomized phase 2 study of sapanisertib in combination with paclitaxel versus paclitaxel alone in women with advanced, recurrent, or persistent endometrial cancer
    Journal Article

    Han, S. N.; Oza, A.; Colombo, N.; Oaknin, A.; Raspagliesi, F.; Wenham, R. M.; Braicu, E. I.; Jewell, A.; Makker, V.; Krell, J.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Low-grade serous ovarian cancer: Expert consensus report on the state of the science
    Journal Article

    Grisham, R. N.; Slomovitz, B. M.; Andrews, N.; Banerjee, S.; Brown, J.; Carey, M. S.; Chui, H.; Coleman, R. L.; Fader, A. N.; Gaillard, S.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Tumor lenvatinib addiction and withdrawal rebound response in patients with advanced endometrial cancer
    Journal Article

    Lam, C.; Sarasohn, D.; Weigelt, B.; Zamarin, D.
    Gynecologic Oncology Reports (2023)

    Fulltext@MSK | Save
  • Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
    Journal Article

    Pignata, S.; Bookman, M.; Sehouli, J.; Miller, A.; Penson, R. T.; Taskiran, C.; Anderson, C.; Hietanen, S.; Myers, T.; Madry, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study
    Journal Article

    Sia, T. Y.; Tew, W. P.; Purdy, C.; Chi, D. S.; Menzin, A. W.; Lovecchio, J. L.; Bookman, M. A.; Cohn, D. E.; Teoh, D. G.; Friedlander, M.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with advanced endometrial cancer treated with lenvatinib plus pembrolizumab or treatment of physician's choice
    Journal Article

    Lorusso, D.; Colombo, N.; Herraez, A. C.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; more...
    European Journal of Cancer (2023)

    Fulltext@MSK | Save